Propofol-induced bradycardia in a pediatric patient undergoing chemotherapy with the known cardiotoxic agent cytarabin.
Wilson
Samuel E
SE
Boyack
Darren A
DA
Ezeife-Ugorji
Ogelue C
OC
Costarino
Andrew T
AT
D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D003561:Cytarabine / Q000009:adverse effects*; D004357:Drug Synergism; D006801:Humans; D007223:Infant; D008297:Male; D015742:Propofol / Q000009:adverse effects*
D018686:Anesthetics, Intravenous; D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D015742:Propofol